Feng Jing, Wang Xiaojuan, Zhu Weihua, Chen Si, Feng Changwei
The Second Affiliated Hospital of Zhengzhou University, Department of Gastroenterology, Zhengzhou, Henan Province, 450014, China.
Biochemistry (Mosc). 2017 Jun;82(6):707-714. doi: 10.1134/S0006297917060074.
In the present study, we investigated the functional role of microRNA (miR)-630 in epithelial-to-mesenchymal transition (EMT) of gastric cancer (GC) cells, as well as the regulatory mechanism. Cells of human GC cell line SGC 7901 were transfected with miR-630 mimic or miR-630 inhibitor. The transfection efficiency was confirmed by qRT-PCR. Cell migration and invasion were determined by Transwell assay. Protein expression of E-cadherin, vimentin, and Forkhead box protein M1 (FoxM1) was tested by Western blot. Moreover, the expression of FoxM1 was elevated or suppressed, and then the effects of miR-630 abnormal expression on EMT and properties of migration and invasion were examined again, as well as protein expression of Ras/phosphoinositide 3-kinase (PI3K)/AKT related factors. The results showed that (i) the EMT and properties of migration and invasion were statistically decreased by overexpression of miR-630 compared to the control group but markedly increased by suppression of miR-630. However, (ii) abnormal expression of FoxM1 reversed these effects in GC cells. Moreover, (iii) expression of GTP-Rac1, p-PI3K, and p-AKT was decreased by miR-630 overexpression but increased by FoxM1 overexpression. (iv) The decreased levels of GTP-Rac1, p-PI3K, and p-AKT induced by miR-630 overexpression were dramatically elevated by simultaneous overexpression of FoxM1. In conclusion, our results suggest that miR-630 might be a tumor suppressor in GC cells. MiR-630 suppresses EMT by regulating FoxM1 in GC cells, supposedly via inactivation of the Ras/PI3K/AKT pathway.
在本研究中,我们调查了微小RNA(miR)-630在胃癌(GC)细胞上皮-间质转化(EMT)中的功能作用及其调控机制。用miR-630模拟物或miR-630抑制剂转染人GC细胞系SGC 7901的细胞。通过qRT-PCR确认转染效率。采用Transwell实验测定细胞迁移和侵袭能力。通过蛋白质免疫印迹法检测E-钙黏蛋白、波形蛋白和叉头框蛋白M1(FoxM1)的蛋白表达。此外,上调或下调FoxM1的表达,然后再次检测miR-630异常表达对EMT以及迁移和侵袭特性的影响,以及Ras/磷脂酰肌醇3-激酶(PI3K)/AKT相关因子的蛋白表达。结果显示:(i)与对照组相比,miR-630过表达使EMT以及迁移和侵袭特性在统计学上降低,但抑制miR-630则使其显著增加。然而,(ii)FoxM1的异常表达逆转了GC细胞中的这些效应。此外,(iii)miR-630过表达使GTP-Rac1、p-PI3K和p-AKT的表达降低,但FoxM1过表达使其增加。(iv)miR-630过表达诱导的GTP-Rac1、p-PI3K和p-AKT水平降低,在同时过表达FoxM1时显著升高。总之,我们的结果表明miR-630可能是GC细胞中的一种肿瘤抑制因子。miR-630可能通过调控GC细胞中的FoxM1抑制EMT,推测是通过使Ras/PI3K/AKT通路失活来实现的。